The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 3, 1999, Pages 858-865

  Dukarm, Robert C ^a   Russell, James A ^a   Morin III, Frederick C ^a   Perry, Bryan J ^a   Steinhorn, Robin H ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [6 CHLORO 4 (3,4 METHYLENEDIOXYBENZYLAMINO) 2 QUINAZOLINYL] 4 PIPERIDINECARBOXYLIC ACID; CYCLIC GMP PHOSPHODIESTERASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; DUCTUS ARTERIOSUS OBLITERATION; FETUS; FETUS SURGERY; HYPERTENSION; LAMB; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION;

EID: 0032873471     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.3.9809120     Document Type: Article

References (39)

1. Abman, S. H., P. F. Shanley, and F. J. Accurso. 1989. Failure of postanatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs. J. Clin. Invest. 83:1849-1858.
2. Morin, F. C., III, 1989. Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb. Pediatr. Res. 25:245-250.
3. Wild, L. M., P. A. Nickerson, and F. C. Morin, III. 1989. Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb. Pediatr. Res. 25:251-257.
4. Abman, S. H., B. A. Chatfield, S. L. Hall, and I. F. McMurtry. 1990. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am. J. Physiol. 259:H1921-H1927.
5. Fineman, J. R., J. Wong, F. C. Morin, III, L. M. Wild, and S. J. Soifer. 1994. Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs. J. Clin. Invent. 93:2675-2683.
6. Beavo, J. A. 1995. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75:725-748.
7. Soderling, S. H., S. J. Bayuga, and J. A. Beavo. 1998. Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases. J. Biol. Chem. 273:15553-15558.
8. Thomas, M. K., S. H. Francis, and J. D. Corbine. 1990. Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase. J. Biol. Chem. 265:14964-14970.
9. Rabe, K. F., H. Tenor, G. Dent, G. Schudt, M. Nakashima, and H. Magnussen. 1994. Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. Am. J. Physiol. 266 (Lung Cell Mol. Physiol. 10):L536-L543.
10. Rabe, K. F., H. Tenor, G. Dent, G. Schudt, M. Nakashima, and H. Magnussen. 1994. Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. Am. J. Physiol. 266 (Lung Cell Mol. Physiol. 10):L536-L543.
11. Sanchez, L. S., S. M. Del La Monte, G. Filippov, R. C. Jones, W. M. Zapol, and K. D. Bloch. 1998. Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase gene expression is regulated during rat pulmonary development. Pdiatr. Res. 43:163-168.
12. Hanson, K. A., F. Burns, S. D. Rybalkin, J. W. Miller, J. Beavo, and W. R. Clarke. 1998. Developmental changes in lung cGMP phosphodiesterase-5 activity, protein, and message. Am. J. Respir. Crit. Care Med. 158:279-288.
13. Zayek, M., L. M. Wild, J. D. Roberts, and F. C. Morin, III. 1993. Effect of nitric oxide on survival and lung injury in newborn lambs with persistent pulmonary hypertension. J. Pediatr. 123:947-952.
14. Roberts, J. D., J. Fineman, F. C. Morin, III, P. W. Shaul, S. Rimar, M. D. Schreiber, R. A. Polin, K. G. Thusu, M. Zayek, M. S. Zwass, T. M. Zellers, M. E. Wylam, I. Gross, W. M. Zapol, and M. A. Heymann. 1997. Inhaled nitric oxide gas improves oxygenation in PPHN. N. Engl. J. Med. 336:605-610.
15. Neonatal Inhaled Nitric Oxide Study Group. 1997. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxie respiratory failure. N. Engl. J. Med. 336:597-604.
16. Shaul, P. W., I. S. Yuhanna, Z. German, Z. Chen, R. H. Steinhorn, and F. C. Morin, III. 1997. Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension. Am. J. Physiol. 272:L1005-L1012.
17. Steinhorn, R. H., J. A. Russell, and F. C. Morin, III. 1995. Disruption of cyclic GMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension. Am. J. Physiol. 268:H1483-H1489.
18. Dukarm, R. C., F. C. Morin, III, J. A. Russell, and R. H. Steinhorn. 1998. Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension. Pediatr. Res. 44:831-837.
19. Black, S. M., M. J. Johengen, and S. J. Soifer. 1998. Coordinated regulation of genes of the nitric oxide and endothelin pathways during the development of pulmonary hypertension in fetal lambs. Pediatr. Res. 44:821-830.
20. Thusu, K. G., F. C. Morin, III, J. A. Russell, and R. H. Steinhorn. 1995. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Am. J. Respir. Crit. Care Med. 152:1605-1610.
21. Braner, D. A. V., J. R. Fineman, R. Chang, and S. J. Soifer. 1993. M&B 22948, a cGMP phosphodiesterase inhibitor, is a pulmonary vasodilator in lambs. Am. J. Physiol. 264:H252-H258.
22. Ichinose, F., C. Adrie, W. E. Hurford, and W. M. Zapol. 1995. Prolonged pulmonary vasodilator action of inhaled nitric oxide by zaprinast in awake lambs. J. Appl. Physiol. 78:1288-1295.
23. McMahon, T. J., L. J. lgnarro, and P. J. Kadowitz. 1993. Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed. J. Appl. Physiol. 74:1704-1711.
24. Skimming, J. W., V. G. DeMarco, P. J. Kadowitz, and S. Cassin. 1996. Effects of zaprinast and dissolved nitric oxide on the pulmonary circulation of fetal sheep. Pediatr. Res. 39:223-228.
25. Ziegler, J. W., D. D. Ivy, J. J. Fox, J. P. Kinsella, W. R. Clarke, and S. H. Abman. 1995. Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus. Am. J. Physiol. 169 (Heart Circ. Physiol. 38):H 473-H479.
26. Ziegler, J. W., D. D. Ivy, J. J. Fox, J. P. Kinsella, W. R. Clarke, and S. H. Abman. 1995. Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus. Am. J. Physiol. 169 (Heart Circ. Physiol. 38):H 473-H479.
27. Ziegler, J. W., D. D. Ivy, J. J. Fox, J. P. Kinsella, W. R. Clarke, and S. H. Abman. 1998. Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus. Am. J. Respir. Crit. Care Med. 157:1104-1110.
28. Saeki, T., H. Adachi, Y. Takase, S. Yoshitake, S. Souda, and I. Saito. 1995. A selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery. J. Pharmacol. Exp. Ther. 272:825-831.
29. Cohen, A. H., K. Hanson, K. Morris, B. Fouty, I. F. McMurtry, W. Clarke, and D. M. Rodman. 1996. Inhibition of cyclic 3′-5′-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats. J. Clin. Invest. 97:172-179.
30. Morin, F. C., III, and E. A. Egan. 1989. The effect of closing the ductus arteriosus on the pulmonary circulation of the fetal sheep. J. Dev. Physiol. 11:245-250.
31. Weibel, E. R. 1991. Design of airways and blood vessels considered as branching trees. In R. G. Crystal and J. B. West, editors. The Lung: Scientific Foundations. Raven Press, New York. 711.
32. Suchomski, S. J., K. G. Mohsini, J. Iwamoto, F. C. Morin, III. 1995. The role of endogenous nitric oxide synthesis in newborn lambs with persistent pulmonary hypertension (abstract). Pediatr. Res. 37:352A.
33. Shaul, P. W., M. A. Farrar, and R. R. Magness. 1993. Pulmonary endothelial nitric oxide production is developmentally regulated in the fetus and newborn. Am. J. Physiol. 265:H1056-H1063.
34. Bloch, K. D., G. Filippov, L. S. Sanchez, M. Nakane, and S. M. dela-Monte. 1997. Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period. Am. J. Physiol. 272:L400-L406.
35. Christou, H., I. Adatia, L. J. VanMarter, J. W. Kane, J. E. Thompson, A. R. Stark, D. L. Wessel, and S. Kourembanas. 1997. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5′-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension. J. Pediatr. 130:603-611.
36. Zayek, M., D. Cleveland, and F. C. Morin, III. 1993. Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. J. Pediatr. 122:743-750.
37. Uematsu, M., Y. Ohara, J. P. Navas, K. Nishida, T. J. Murphy, R. W. Alexander, R. M. Nerem, and D. G. Harrison. 1995. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am. J. Physiol. 269:C1371-C1378.
38. Dukarm, R. C., R. H. Steinhorn, and J. J. Cummings. 1998. Pulmonary vascular effects of PDE 5 inhibition with E4021 in near term fetal lambs (abstract). Circulation 98:1-342.
39. Murphy, J. D., M. Rabinovitch, J. D. Goldstein, and L. M. Reid. 1981. The structural basis of persistent pulmonary hypertension of the newborn infant. J. Pediatr. 98:962-967.